Siegfried has inked a deal to acquire Curia Global’s early-phase manufacturing site in Grafton, Wisconsin, in a move that expands the Swiss CDMO’s reach in the U.S. and its ability to offer a wider range of services. The sale comes a little more than two months after Siegfried’s chief executive was poached by rival Lonza. Although financial details of the facility purchase from Curia weren’t disclosed, the sale is expected to wrap up by July 1 and is being financed from existing company funds, Siegfried said in a June 12 press release. The Wisconsin facility specializes in early-phase development and manufacturing services and employs more than 80 workers. Siegfried said it plans to develop the site into a hub for early-phase CDMO services for its global customers, which will include services for projects with highly potent drug ingredients.
Read the full article: CDMO Siegfried Expands US Footprint with Acquisition of Wisconsin Facility //
Source: https://www.fiercepharma.com/manufacturing/cdmo-siegfried-expands-us-footprint-acquisition-wisconsin-facility